Visual storytelling for medical publications

Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial

#Mepolizumab reduced the number of exacerbations in #urban #children with exacerbation-prone eosinophilic #asthma, #MUPPITS2 study finds

https://bit.ly/3plfXTy
#VisualAbstract #DataViz #USA #eosinophilicasthma #in